Delivery Order SPE2DB24D2205-SPE2DB24FDVCP

Award Date 6/5/24
Potential Completion Date 6/6/24
Potential Value $1.9K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, for the provision of Eliquis 5 mg tablets. The contract is a Delivery Order valued at $16,315.25 with a completion date of August 30, 2022. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Eliquis 2.5 mg tablets. The $7,862.40 firm-fixed-price contract has a completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 2.5 mg tablet 60s. The $1,900.08 firm-fixed-price Delivery Order has a completion date of September 13, 2024 and is not designated as a set-aside contract. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for...
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,900.08 firm fixed-price delivery order is for the supply of Eliquis 2.5 mg tablets. The award is not associated with a set-aside designation. The delivery order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
This federal contract award is for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA) Troop Support Medical. The $27,138.08 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, with no set-aside designation. The contract has an ultimate completion date of May 29, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The firm-fixed-price delivery order, valued at $15,470.22, has a period of performance through November 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The single-award contract has a ceiling value of $4,287.52 and a period of performance through January 24, 2025. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a separate $999,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award from the Defense Logistics Agency (DLA) was made to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The $23,951.03 firm fixed price contract has an ultimate completion date of October 24, 2024. It is a delivery order under a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The $5,435.76 firm fixed-price contract has an ultimate completion date of August 28, 2024. This award is a delivery order placed against a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical for providing...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, covers the delivery of Eliquis 5 mg tablets for the Defense Logistics Agency (DLA). The $7,600.32 firm fixed-price delivery order has an ultimate completion date of October 25, 2024. The award is not designated under any set-aside program, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FDVCP
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 2.5 mg tablets. The fixed-price delivery order, valued at $1,900.08, has a completion date of June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This award is not associated with a set-aside program.

Generated 9/4/24, 9:16 AM